Share of drug production value Japan 2023, by category
In 2023, antineoplastics accounted for around 13.4 percent of the total drug production value in Japan. Central nervous system agents followed with a share of 10.9 percent.
In 2023, antineoplastics accounted for around 13.4 percent of the total drug production value in Japan. Central nervous system agents followed with a share of 10.9 percent.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Overview
Production
Sales
Sales of prescription drugs
International trade
Expenditure
Approval and patent
Leading companies
Further related statistics
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.